Novotech Health Holdings Pte Ltd
•
Dec 16, 2022 07:00 HKT/SGT
以亞太地區為中心的生物技術專家 CRO Novotech 表示,GlobalData 和 Novotech 最新發布的行業研究報告發現,近 50% 的新試驗都在亞太地區進行。根據題為《全球生物技術現狀:機遇所在》的新出版物,對亞太地區試驗地點的需求強勁,2021 年啟動的 27,000 多項臨床試驗中,近一半在亞太地區設有地點。數據顯示,近12,900 項新試驗的地點位於亞太地區。在這裡下載報告 https://novotech-cro.com/whitepapers/state-global-biotech-landscape-where-opportunities-lie 該報告還指出,亞
Novotech Health Holdings Pte Ltd
•
Dec 16, 2022 07:00 HKT/SGT
以亚太地区为中心的生物技术专家 CRO Novotech 表示,GlobalData 和 Novotech 最新发布的行业研究报告发现,近 50% 的新试验都在亚太地区进行。根据题为《全球生物技术现状:机遇所在》的新出版物,对亚太地区试验地点的需求强劲,2021 年启动的 27,000 多项临床试验中,近一半在亚太地区设有地点。数据显示,近12,900 项新试验的地点位于亚太地区。在这里下载报告 https://novotech-cro.com/whitepapers/state-global-biotech-landscape-where-opportunities-lie 该报告还指出,亚
ACN Newswire
•
Dec 15, 2022 23:10 HKT/SGT
The 20th edition of the World Cloud & Data Center Show took place at the InterContinental, Riyadh, on November 28 – 29, 2022, and brought together elite IT leaders from Saudi Arabia and around the world to witness the newest advancements in cloud and data center technologies. Throughout th
Ni Hsin Group Berhad
•
Dec 15, 2022 18:00 HKT/SGT
Ni Hsin EV Tech Sdn. Bhd., a wholly-owned subsidiary of Main Market-listed Ni Hsin Group Berhad (formerly known as Ni Hsin Resources Berhad (Bursa: NIHSIN, 7215)), today signed a Strategic Collaboration with SIRIM Berhad to promote co-operation between the Parties in the following areas:(a) setting
ACN Newswire
•
Dec 15, 2022 17:35 HKT/SGT
Spanning over 3 days, the India International Furniture Fair effectively won over its visitors. The fourth edition of the IIFF, which took place from December 2–4, welcomed more than 4000 attendees to the International Expo Center in Noida. Noida, India, Dec 15, 2022 - (ACN Newswire) - The fo
Bank of China
•
Dec 15, 2022 17:00 HKT/SGT
The Hong Kong Trade Development Council (HKTDC) projects that Hong Kong's exports will grow 5% next year - a recovery from the 6% decline this year. HKTDC Director of Research Irina Fan said: "Hong Kong's exports will gradually regain growth momentum amid the receding pandemic, easing
ACN Newswire
•
Dec 15, 2022 16:30 HKT/SGT
Acin, the global operational risk control data network, today announced it has closed $24 million in Series B funding from a strategic consortium of industry-leading banks, comprised of JP Morgan, Citi, BNP Paribas, Barclays, and Lloyds Banking Group.The funding round was also supported by existing
Anta Sports Products
•
Dec 15, 2022 15:39 HKT/SGT
恒生指数成分股中的企业在其ESG报告质量方面排于全球中等水平。这是Global ESG Monitor(GEM)2022年香港区域报告最新所得出的研究。GEM最新研究发现,作为恒生指数成分股的港股上市公司在非财务报告的透明度方面平均得分为57分(以最高分100分计),此意味着恒生指数成分股在此方面的排名处于同样被GEM调研的欧洲、北美、亚洲和澳洲的10大股票市场多个国际指数当中中档偏下的位置,排名仅仅高于标准普尔亚洲(56分)和澳洲ASX50(53分)的水平。GEM香港区域报告指出,在恒生指数当中,名列前茅的三家公司分别为,安踏体育(02020.HK)、恒生银行(00011.HK)和腾讯控股(
Anta Sports Products
•
Dec 15, 2022 15:38 HKT/SGT
恒生指數成分股中的企業在其ESG報告質量方面排於全球中等水平。這是Global ESG Monitor(GEM)2022年香港區域報告最新所得出的研究。GEM最新研究發現,作為恒生指數成分股的港股上市公司在非財務報告的透明度方面平均得分爲57分(以最高分100分計),此意味著恒生指數成分股在此方面的排名處於同樣被GEM調研的歐洲、北美、亞洲和澳洲的10大股票市場多個國際指數當中中檔偏下的位置,排名僅僅高於標準普爾亞洲(56分)和澳洲ASX50(53分)的水平。GEM香港區域報告指出,在恒生指數當中,名列前茅的三家公司分別為,安踏體育(02020.HK)、恒生銀行(00011.HK)和騰訊控股(
Anta Sports Products
•
Dec 15, 2022 15:37 HKT/SGT
Companies in the Hang Seng Index rank in the midrange internationally in terms of the quality of their ESG reporting. This is the finding of the Global ESG Monitor 2022 (GEM), Regional Report Hong Kong/ China published today. The GEM is considered an international leader in analysing the non-financi
Legend Capital
•
Dec 15, 2022 12:30 HKT/SGT
Legend Capital Portfolio Company Bespin Global, a Korea-headquartered cloud services company, has recently completed its Series D round financing of USD100 million, which will be used mostly for acquisitions.Concurrent with the investment, the investor, e& Enterprise, a leading digital services
Novotech Health Holdings Pte Ltd
•
Dec 15, 2022 10:00 HKT/SGT
Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of new trials had sites in Asia Pacific.According to the new publication titled "State of the Global Biotech Landscape: Where the Opportunities Li
ACN Newswire
•
Dec 15, 2022 10:00 HKT/SGT
Fight Zone, a born-in-Singapore fitness brand today announced the opening of its first franchised outlet at Suntec City. Located in the heart of Singapore's business district, the outlet will also be the first among its outlets to focus on physical transformation of clients and muaythai, moving
PropertyGuru Group
•
Dec 15, 2022 09:38 HKT/SGT
PropertyGuru Group (NYSE: PGRU), Southeast Asia's leading property technology company, has returned its thought leadership platform, the PropertyGuru Asia Real Estate Summit (ARES), to the physical stage, drawing the most brilliant minds from around the world to the Thai capital. Following the
ACN Newswire
•
Dec 15, 2022 07:30 HKT/SGT
SIGGRAPH Asia 2022가 대한민국 대구에서 나흘간의 무역 컨퍼런스와 전시회를 성공적으로 마치고 폐막 50개 국가와 지역에서 온 컴퓨터 그래픽과 몰입형 기술 분야의 뛰어난 인재들이 차세대 기술 발전을 고무 컴퓨터 애니메이션, 기술 논문, 확장 현실 및 실시간 라이브 부문의 권위 있는 상을 수여받은 인재들! Daegu, South Korea, Dec 14, 2022 - (ACN Newswire) - ACM SIGGRAPH 아시아 지역 컴퓨터 그래픽 및 인터랙티브 기술에 관한 연례 컨퍼런스와 무역 전시회, 제15회S
Sirnaomics Ltd.
•
Dec 14, 2022 23:17 HKT/SGT
Sirnaomics Ltd.( “公司”,“Sirnaomics”,股份代号:2257.HK),是一家行业领先的专注于探索及开发RNAi疗法的生物制药公司。Sirnaomics本日公布正在进行的STP705用于治疗原位鳞状细胞皮肤癌(isSCC)的IIb期第一阶段的中期临床数据。该中期数据结果显示,在32名使用STP705疗法的患者中,大多数(78%)到达了主要终点(肿瘤细胞完全组织学清除)。三组队列中,最优效果组实现了89%到达主要终点。STP705是一种siRNA(小干扰核酸)疗法,利用双靶向抑制特性和多肽纳米颗粒(PNP)增强递送效率来直接敲低TGF-β1和COX-2基因表达。本项由两
Sirnaomics Ltd.
•
Dec 14, 2022 23:16 HKT/SGT
Sirnaomics Ltd.( 「公司」,「Sirnaomics」,股份代號:2257.HK),是一家行業領先的專注於探索及開發RNAi療法的生物製藥公司。Sirnaomics本日公佈正在進行的STP705用於治療原位鱗狀細胞皮膚癌(isSCC)的IIb期第一階段的中期臨床數據。該中期數據結果顯示,在32名使用STP705療法的患者中,大多數(78%)到達了主要終點(腫瘤細胞完全組織學清除)。三組隊列中,最優效果組實現了89%到達主要終點。STP705是一種siRNA(小干擾核酸)療法,利用雙靶向抑制特性和多肽納米顆粒(PNP)增強遞送效率來直接敲低TGF-β1和COX-2基因表達。本項由兩
Sirnaomics Ltd.
•
Dec 14, 2022 23:15 HKT/SGT
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the interim results of part-one of an ongoing Phase IIb clinical trial of STP705 for the treatment of Cutan
ACN Newswire
•
Dec 14, 2022 21:45 HKT/SGT
Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company's groundbreaking research that led to promising novel drug candidates for cardiovascular disease. Card
EC Healthcare
•
Dec 14, 2022 21:38 HKT/SGT
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, is pleased to announce the Group has garnered the "Best in Healthcare Sector" at IR Magazine&ap